Impact of glucocorticoids on patients’ quality of life: a qualitative study assessing face validity and feasibility of the Steroid PRO in patients with inflammatory gastroenterology, respiratory and dermatology conditions
Impact of glucocorticoids on patients’ quality of life: a qualitative study assessing face validity and feasibility of the Steroid PRO in patients with inflammatory gastroenterology, respiratory and dermatology conditions
Shaney Barratt, Christine Silverthorne, Catherine Hill, Susan M. Goodman et al.
Citations
1 citations
Journal
BMJ Open
Topics
Dermatology and Skin Diseases
Field-Weighted Citation Impact (FWCI)
2.00
article
Impact of glucocorticoids on patients’ quality of life: a qualitative study assessing face validity and feasibility of the Steroid PRO in patients with inflammatory gastroenterology, respiratory and dermatology conditions
Shaney Barratt, Christine Silverthorne, Catherine Hill, Susan M. Goodman, Joanna Robson, A Sweeney, Emma Dures, Jill Dawson, Tom Creed, Mwidimi Ndosi, Michelle Sharp, Genevieve Osborne, Sebastian Eduardo Sattui, Richard P. Ramonell, Timothy Patton, Susan Bridgewater, E Arthurs, Pamela Richards, Sarah Mackie, Jen Orme, Giles Dunhill
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(2)
Institutions
North Bristol NHS Trust (GB), University of Leeds (GB), Johns Hopkins University (US), University of Pittsburgh (US), University of the West of England (GB), Cornell University (US), Leeds Teaching Hospitals NHS Trust (GB), Johns Hopkins Medicine (US), University Hospitals Bristol NHS Foundation Trust (GB), University of Oxford (GB), Queen Elizabeth Hospital (AU), NIHR Leeds Musculoskeletal Biomedical Research Unit (GB), Weill Cornell Medicine (US), University Hospitals Bristol and Weston NHS Foundation Trust (GB), The University of Adelaide (AU)
Funders
Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Yale University, Rheumatology Research Foundation, University of Pittsburgh, Hospital Research Foundation, National Institute for Health and Care Research, University of Oxford, University of Leeds, Arthritis Australia, University of the West of England, Vifor Pharma, National Institutes of Health, Genentech, Chugai Pharmaceutical, Medical Research Council, Leeds Biomedical Research Centre, National Heart, Lung, and Blood Institute